Compare CTNM & BRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CTNM | BRSP |
|---|---|---|
| Founded | 2009 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Real Estate Investment Trusts |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 550.7M | 528.9M |
| IPO Year | 2024 | 2017 |
| Metric | CTNM | BRSP |
|---|---|---|
| Price | $9.57 | $3.28 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 8 |
| Target Price | ★ $21.43 | $5.75 |
| AVG Volume (30 Days) | 596.9K | ★ 1.9M |
| Earning Date | 11-03-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 19.94% |
| EPS Growth | 0.46 | ★ 75.24 |
| EPS | N/A | ★ 0.25 |
| Revenue | N/A | ★ $330,587,000.00 |
| Revenue This Year | N/A | $4.72 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $12.84 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.73 | $3.05 |
| 52 Week High | $17.79 | $6.17 |
| Indicator | CTNM | BRSP |
|---|---|---|
| Relative Strength Index (RSI) | 46.25 | 37.41 |
| Support Level | $8.59 | N/A |
| Resistance Level | $13.72 | $3.87 |
| Average True Range (ATR) | 0.77 | 0.16 |
| MACD | 0.23 | -0.01 |
| Stochastic Oscillator | 42.33 | 26.33 |
Contineum Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of oral small-molecule therapies for neurological, inflammatory, and immunological conditions. The company focuses on developing selective compounds targeting challenging molecular pathways and has built a portfolio of small molecule drug candidates. Its pipeline includes drug candidates in clinical development, such as PIPE-791, an LPA1 receptor antagonist being studied for idiopathic pulmonary fibrosis and chronic pain, and PIPE-307, an M1 receptor inhibitor being evaluated for relapsing-remitting multiple sclerosis and other depressive disorders.
BrightSpire Capital Inc is an internally-managed commercial real estate credit REIT focused on originating, acquiring, financing and managing a diversified portfolio of commercial real estate debt and net lease real estate investments predominantly in the United States. CRE debt investments consist of first mortgage loans with the objective of generating consistent risk-adjusted returns. The operating segments of the company are Senior and Mezzanine Loans and Preferred Equity, Net Leased and Other Real Estate, Corporate and Other. Geographically, the company generates revenue from the United States.